ABSTRACT
INTRODUCTION
The ability to compare two different DNA libraries has permitted studies into the role of differentially expressed genes or genomic deletions involved in the mechanisms of neoplastic transformation, developmental regulation, therapeutic effects, pathological disorders and cell-physiological phenomena. Understanding the alterations of gene expression and chromosomal rearrangement between normal and disordered cells is important for gene therapy, eugenical improvement, pharmaceutical design and etiological investigation.
Several methods have been designed to detect and isolate different DNA sequences that are present in one complementary (7) or genomic DNA (4) library but absent in another. The most commonly used method is subtractive hybridization, such as representational difference analysis (RDA), which involves the elimination of homologous sequences from the mixture of two mutually compared DNA libraries. This method relies upon the generation of representative DNA libraries from both control cells (subtracter) and cells of experimental treatments, disorders or morphological/functional changes (tester). The two DNA libraries are then denatured and mixed, resulting in the formation of subtracter/tester hybrid duplexes when two sequences are common to both DNA populations. By removing the surplus subtracter and common sequences, the DNAs remaining are the desired different sequences present only in the tester, which is highly related to the treatments, disorders or changes of interest.
Previously, aziridinylbenzoquinone (AZQ), an interstrand, cross-linking agent, has been used to covalently subtract common sequences from compared libraries (2, 3) . In this method, single-stranded tester and subtracter were mixed to form hybrid duplexes first, and then the AZQ was added to generate covalent bonds between the hybrid duplexes. The formation of unseparable hybrids greatly increased the completion of homology subtraction through hybridization. However, AZQ cross-links nucleotides nonspecifically, and only the single-stranded tester and subtracter could be utilized as samples during subtractive hybridization, resulting in no detection of genomic DNA samples and no generation of rare amounts of cDNA samples.
We have developed a newly improved subtractive hybridization method, the covalent homology subtraction (CHS) assay, to screen differently existing sequences between two cDNA or genomic DNA libraries. This method was designed primarily for quick isolation of differentially expressed genes, detection of large genomic deletions or insertions and searching for chromosome-specific loci. The principle of CHS is that covalent bond formation between homologous sequences inhibits the procedure of polymerase chain reaction (PCR) or cloning (Figure 1 ), resulting in no amplification of the homologues. Because the covalent bonds occur specifically between a carboxylated group at C-5 uracil (thymine)/C-6 cytosine of subtracter and an amino group at the C-6 adenine/C-2 guanine of tester, respectively (Figure 2 ), this covalent pairing feature significantly increases the specificity of homology subtraction and the sensitivity of detection. Also, during this subtractive hybridization, the
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Biotechniques 26: 966-979 (May 1999) Research Repo r ts affinity of homologous sequences can be greatly enhanced by the covalent binding that fully accomplishes the completion of homology subtraction, and therefore, reduces both the amount of subtracter needed and the number of subtraction cycles.
MATERIALS AND METHODS

Oligonucleotides
Sequences of oligonucleotides used in the CHS assay were as follows: tester-24-mer (5 ′ -GCCACCAGAAGA -GCGTGTACGTCC-3 ′ ), tester-11-mer (5 ′ -CGGGACGTACA-3 ′with a dephosphorylated 5 ′ -end), Subtracter-24-mer (5 ′ -CGGTAGTGACTCGGTTAA-GATCGC-3 ′ ) and subtracter-11-mer (5 ′ -CGGCGATCTTA-3 ′ with a dephosphorylated 5 ′ end). The 24-mer oligonucleotides were used as 5 ′ adapters and primers for PCR, while the 11-mer oligonucleotides functioned as linkers for the ligation of the 5 ′ end adapters.
General Methods
All routine techniques and DNA manipulations, including gel electrophoresis, plasmid preparations and transformations, were performed according to standard procedures (10) . All enzymes and buffer treatments were applied following the manufacturer's protocols (Boehringer Mannheim, Indianapolis, IN, USA). For northern and Southern blot hybridizations, mRNAs or restricted genomic DNAs were fractionated on 1% formaldehyde-agarose gels and transferred onto nylon membranes (Schleicher & Schuell, Keene, NH, USA). Probes were labeled with the Prime-It ® II Kit (Stratagene, La Jolla, CA, USA) by random primer extension in the presence of [ 32 P]dATP (>3000 Ci/mM; Amersham Pharmacia Biotech, Piscataway, NJ, USA) and purified with Micro Bio-Spin ® Chromatography Columns (Bio-Rad, Hercules, CA, USA). Hybridization was carried out in the mixture of 50% freshly deionized formamide (pH 7.0), 5 × Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), 4 ×sodium chloride sodium phosphate EDTA (SSPE) and 250 µ g/mL denatured salmon sperm DNA (18 h at 42°C). Membranes were washed twice in 2 × standard saline citrate (SSC), 0.1% SDS (15 min at 25°C), followed by once each in 0.2 × SSC, 0.1% SDS (15 min at 25°C) and 0.2 × SSC, 0.1% SDS (30 min at 65°C) before autoradiography.
Cell Culture and Activin Treatment
LNCaP cells, a prostate cancer cell line from ATCC (Rockville, MD, USA), were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and 100 µ g/mL Figure 1 . Schematic protocol for the CHS assay, illustrating the covalently bonded hybrid formation between tester and subtracter DNA and the differential amplification steps after subtractive hybridization. The process is shown up to the final products of the first round of the CHS assay. To reiterate another round of subtraction, the first difference products are used as tester, following the same scheme, to generate the second difference products and so on. gentamycin at 37°C under 10% CO 2 . For a three-day activin induction, six 100-mm dishes of LNCaP cells were treated with 200 ng/mL activin (2.5 mL) per day, while four other dishes of cells were treated with only medium as control. On the fifth day after the first treatment, 56% reduction in growth was observed in the activin-treated cells compared to the control by both microscopy and cell counting as previously reported (15, 17) . The two groups of cells were separately trypsinized, and total RNAs were isolated with TRI ZOL ® reagent (Life Technologies, Gaithersburg, MD, USA). mRNAs were purified from total RNAs with poly(dT) dextran columns (Qiagen, Valencia, CA, USA), and the quality of the mRNAs was assessed on 1% formaldehyde-agarose gels. Also, genomic DNAs were isolated by QIA-GEN ® Genomic-tips (Qiagen) following the manufacturer's protocol.
Full-Length cDNA Library Preparation
The first strand of cDNAs was prepared by reverse transcription of mRNAs with an oligo(dT) 20 primer following the manufacturer's protocol of a cDNA Cycle Kit (Invitrogen, Carlsbad, CA, USA) and recovered by ethanolprecipitation with 2 µ g of glycogen at -20°C overnight. To generate the poly(dA) + template in the 3 ′ end of the first-strand cDNA for full-length cDNA amplification, the tailing reaction of cDNAs was performed in a 25-µ L mixture of terminal transferase, RNase H and 0.2 mM dATP for 20 min at 37°C. The dA-tailed cDNAs were directly amplified by PCR with the oligo(dT) 20 primer (1 min incubation at 95°C, 1 min at 55°C and 3 min at 72°C). After thirty cycles of amplification, the quality of the full-length, double-stranded cDNA library was assessed on a 2% agarose gel, ranging from 150 bp to 9 kb.
Generation of Representative PCR Product
To generate adequate length of nucleotide products for efficient subtraction and amplification, double-stranded cDNAs (1.5 µ g) were digested with a four-cutting enzyme, as Hpa2, recovered by Amicon ® microconcentrator columns (Millipore, Bedford, MA, USA) and then prepared for ligation to either tester-24/11-mer or subtracter-24/11-mer adapter in a mixture containing the 24/11-mer oligonucleotide (0.75 nmol each) in 30 µ L of 1 × ligase buffer. For precise ligation between restricted cDNA and adapter, the mixture was held by gradually cooling from 50°t o 10°C over a period of 1 h, and then 400 U of T 4 ligase were added to anneal the 24-mer oligonucleotide onto the 5 ′ end of double-stranded cDNAs at 16°C for 14 h. The procedure described above formed the representative products for both tester and subtracter respectively, depending on the adapter used. The product of genomic DNAs was generated as described above, with the exception that the initial sample was genomic DNA instead of cDNA.
Generation of Covalently Modified Subtracter
Multiple PCRs were set up as follows: each 50 µ L reaction mixture contained subtracter product (100 ng), 1 µ M subtracter-24-mer oligonucleotide, dNTP mixture (0.2 mM for each dATP, dCTP, dGTP, dTTP and 0.1 mM dUTP) and TaqDNA polymerase (5 U) in 1 × PCR buffer. The 11-mer linker was melted away (3 min at 72°C), and the recessed 3 ′ ends were filled in with Taq DNA polymerase (3 min at 72°C). Thirty cycles of amplification were performed (1 min at 95°C and 3 min at 72°C), and the products were combined and recovered by a microconcentrator column in 10 µ L of Tris buffer (10 mM, pH 7.4). Pure acetic anhydride (50 µ L) was added (5 min at 98°C) into the resuspended subtracter DNA to block the amino group of a nucleotide by acetylation, which also made the subtracter become single-stranded. After the acetylated subtracter was recovered by a microconcentrator column in 20 µ L of Tris buffer, hot alkaline potassium permanganate (0.1 M, pH 10.0) was added (3 min at 80°C) to generate carboxyl groups on the subtracter pyrimidines, which can covalently bond to the amino groups of tester purines. The carboxylated subtracter was finally recovered by a microconcentrator column in 3
The quality of modified subtracter (2 µ g) was assessed on a 2% agarose gel, ranging from 70 bp to approximately 1 kb.
Subtractive Hybridization and Differential Amplification
For the first subtractive hybridization, 0.2 µ g of tester product was mixed with 10 µ L of modified subtracter, overlaid with mineral oil, denatured (5 min at 98°C) and added with 5 M NaCl (2 µ L) to adjust salt concentration. The incubation of this mixture was continued at 70°C for 16 h to form hybrid duplexes. The hybrids were diluted with 20 µ L of MgCl 2 solution (2.5 mM), and then a PCR mixture (50 µ L) was prepared containing 2 µ L of the hybrid, 1 µ M tester-24-mer oligonucleotide, dNTP mixture (0.2 mM each for dATP, dCTP, dGTP and dTTP) and TaqDNA polymerase (5 U) in 1 ×PCR buffer. The tester-11-mer was melted away (3 min at 72°C), and the recessed ends were filled by TaqDNA polymerase (3 min at 72°C). Thirty cycles of PCR amplification were performed (1 min at 95°C and 3 min at 72°C), and the product was assessed on a 3% agarose gel. The DNA bands shown on the gel were excised and recovered by a QIAquick ™ Gel Extraction Kit (Qiagen) to give the final difference products and then were further purified by a 4% non-denatured polyacryamide gel. The processes of subtractive hybridization with modified subtracter and selective amplification can be repeated until clear bands are observed on the gel. Both cDNAs and genomic DNAs were processed in the same matter as mentioned above.
Cloning and Sequencing of Difference Products
Final products of the CHS assay were ligated to pCR ® 2.1 plasmid and transformed into INVα F ′ cells with TA Cloning ® Kit (Invitrogen). Doublestranded plasmid DNA was purified by Miniprep Spin Columns (Qiagen) and sequenced by Sequenase ® Version 2.0 DNA Sequencing Kit (Amersham Pharmacia Biotech) with dideoxy-mediated chain termination. Resulting sequences were searched and compared to the GenBank ® database using the Basic Local Alignment Search Tool (BLAST) program from the National Institutes of Health (NIH).
Antisense Knock-Out Assay
Final products of the CHS assay were used as probes in northern blots and antisense transfections. Following the single-stranded amplification method reported by Medori et al. (8) , 100 ng of final product from the CHS assay were used in a 100-µ L reaction containing 30 pmol of antisense primer, 0.3 pmol of sense primer, dNTPs (0.2 mM each), TaqDNA polymerase (5 U) and 1 ×PCR buffer with 1.5 mM MgCl 2 . The thirty-cycle PCR amplification was carried through denaturation at 95°C for 1 min, annealing at 55°C for 1 min and extension at 72°C for 3 min. The antisense PCR product was recovered by a microconcentrator column in HEPES buffer (20 mM, pH 7.4) and modified with Covalent Modification Reagent (Epiclone, Alhambra, CA, USA) to introduce covalent bonding capability between the modified probe and its target nucleotide sequence. e) will cause no amplification due to the specific affinity of the primer to its own adapter.
three-day activin treatment and a twoday incubation as described above, genomic DNA was isolated by an apoptotic DNA Ladder Kit (Boehringer Mannheim) and assessed on a 2% agarose gel. The cell growth and morphology were also examined.
RESULTS
Screening of Differentially Expressed Transcripts between Nontreated and Activin-Treated LNCaP Cells
As shown in Figure 3 , when activintreated tester was covalently subtracted by untreated subtracter, three bands ( Figure 3 , lane i) were obtained only in the activin-treated cells, which contained seven gene fragments, including three transcriptional products increased twofold above the controls. These products are rBub-like homologue (LT6), p53and a novel gene. On the other hand, when untreated tester was subtracted by activin-treated subtracter, three bands (Figure 2 , lane h) were obtained only in the untreated cells, which contain thirteen gene fragments, including six transcriptional products decreased to as low as 45% of the controls. These products are myosin-like homologue, hyaluronan receptor, helicase motif-like homologue, Pax2 , eIF-4A1 and a novel gene. The three up-regulated gene products represent the genes involved in enhancing activin-induced cell-cycle arrest and apoptosis (6, 16) , whereas the six down-regulated genes indicate that the expression of these genes would be reduced in cellcycle arrest or apoptosis (1, 5, 11, 13, 14) . Previously, p53has been shown (16) to be up-regulated in activin-mediated inhibition of cell proliferation and enhancement of apoptosis in LNCaP cells. Indeed, the p53gene was identified by the CHS method and is known to be involved in the G1 phase arrest of cell cycle and the induction of apoptosis.
High Specificity and Low Background of CHS Assay
No sequence (Figure 3 , lanes f and g) was found when a cDNA library was subtracted with itself (treated to treated and untreated to untreated, respectively) and then amplified by thirty cycles of PCR, suggesting that the identification of differentially expressed genes is highly specific. In addition, the crossreaction between tester and subtracter was completely inhibited by specially designed adapters and primers that were totally inert to each other under our PCR conditions (Figure 3, lanes d  and e) . Moreover, there was no significant difference between the first round and the second round of the CHS assay in this present model, indicating that a complete subtraction was achieved. This method is sensitive because rare genes such as Pax2 (1) GI arrest a n = 3, P <0.01. b n = 4, P <0.01.
The p53(LT11) has been known to be up-regulated in the activin-treated LNCaP cells. The down-regulated known genes (LC2, 3, 9, 12 and 13) in the upper panel are related to physiological functions of cells, and the up-regulated known genes (LT6 and 11) are involved in either cell-cycle regulation or apoptosis or both. All genes listed are transcriptionally altered at least twofold. The size of each identified gene transcript is deduced from individual northern blot, and the homology shown here indicates the resemblance sequence between the identified fragment and its deduced gene, rather than the full identified sequence. Research Repo r ts obtained from RDA, the CHS assay has the advantages of low background and high efficiency, and usually the same results were obtained after one round of subtractive hybridization, even when cDNA libraries from tissues were used (data not shown).
Confirmation of Transcriptional Alterations by Northern Blots
All genes obtained from the CHS assay were confirmed by northern blots, which provide direct evidence for the identified alterations of gene expression. Each identified gene fragment was subjected, at least three times, to northern blots hybridized with mRNA libraries from different sets of cells after the same treatment. Only a fragment showing twofold changes with a P <0.01 was considered as a positive result. Nine positive results were found, including three clones from activintreated cells and six clones from nontreated control cells (Figure 4) . The three up-regulated genes are related to either cell-cycle arrest or apoptosis, and the six down-regulated genes are involved in the maintenance of cell physiology ( Table 1 ). The mRNA length of a positive clone was then deduced from the blots and used to match its original gene with sequence data from the GenBank. Instead of northern blots, Southern blots of cDNA can be applied to confirm the positive results. However, we do not prefer Southern blots, which can introduce potential false-positive results due to a bad cDNA library.
Functional Assay of Stimulated Novel Genes in Apoptotic Cells with Antisense Knock-Out Transfections
Because the different products identified by the CHS assay are partial fragments restricted from original gene transcripts, an antisense knock-out transfection is the fastest way to test the possible functions of these genes. However, not all identified genes can be directly linked to the activin-induced apoptosis of LNCaP cells, in which some genes might only be involved in cell-cycle arrest or are indirectly influencing apoptosis. Here, we display one of the most significant novel genes, rBub-like homologue (LT6), to demonstrate the use of antisense knock-out transfection for increasing the understanding of the relationship between apoptosis and the identified genes.
The knock-out result ( Figure 5 ) indicated that the antisense oligonucleotide of LT6 can rescue activin-treated LNCaP from apoptotic DNA fragmentation, whereas the sense oligonucleotide of LT6 has no effect. The proliferation rate and morphology of activin-treated LNCaP cells were also changed after antisense knock-out of the LT6 oligonucleotide. Not only were more spindle-like cells observed to proliferate in the culture similar to nontreated cells, but also there was a 73% rescue effect in cell growth after transfecting antisense-LT6 oligonucleotide into activin-treated cells. The transfection of either sense-LT6 oligonucleotide or liposome carrier only had no effect on cell apoptosis and morphology after activin treatment, indicating that the knock-out results are highly sequence-specific. Therefore, the CHS assay and antisense knock-out transfection can work together to allow a fast screening for novel genes, which can provide a quick preview for understanding their novel functions.
DISCUSSION
The CHS assay was designed to improve the subtractive hybridization for screening different sequences between two cDNA or genomic DNA libraries. It allows for quick isolation of differently expressed genes (either up-or down-regulated), easy detection of large genomic deletions/insertions and precise identification of chromosomespecific loci. The principle of the CHS assay is dependent on the subtraction force of covalent bonding between homologous sequences of two DNA libraries during PCR or cloning, resulting in no amplification of the homologues. As used in this study, tester refers to the DNA library isolated from a treated, mutated, infected differentiated or abnormal cell source, while subtracter refers to the DNA library isolated from a cell source with different status, such as nontreated, un-or further-differentiated or relatively normal cells (or tissues containing homogeneous cells). The tester DNA library contains different sequences that are abundant in the tester but very limited in the subtracter. The desired sequences represent the differences of gene expression (if a cDNA library is used as the sample) or those of genomic complexity (if a genomic DNA library is used as the sample).
The isolation of the desired sequences was achieved by using a covalently modified subtracter to remove homologues, through hybridization and covalent bond formation, between the modified subtracter and a non-modified tester homologue. The covalent modification of subtracter is completed with an amino-blocking agent and a carboxylating agent. The amino-blocking agent is a chemical that can block the amino group of nucleotides, such as alkaline acetic chloride, and the carboxylating agent is a reagent that can generate carboxyl groups on certain nucleotides of the subtracter, such as hot alkaline potassium permanganate. The amino-blocking reaction is preferably carried out by acetylating the amino group of purine to form an inactive acetamido group (12) , which prevents the reassociation of subtracter. Because the single-stranded subtracter cannot protect its nucleotides from oxidation any more, a carboxylating agent oxidizes the C5=C6 alkene group of pyrimidines into carboxyl groups available for the formation of covalent bonds (9) . During subtractive hybridization, the affinity of subtracter to homologous tester is greatly enhanced by the covalent modification described above; a carboxyl group on the C-5 uracil (thymine)/C-6 cytosine of subtracter, resulting in peptide-like bonding to the amino group on the C-6 adenine/C-2 guanine of tester, respectively ( Figure  2 ). Such covalent bond formation between subtracter and tester fully accomplishes the homology subtraction. Also, the modified subtracter remains single-stranded by the amino-blocking agent, which significantly increases the reannealing efficiency of tester-subtracter hybrids, but not that of subtracter-subtracter reassociation, and therefore, reduces the needed amount of subtracter. Furthermore, because covalent bonding is an internal affinity between guanine and cytosine to adenine and thymine, these covalent pairing features significantly increase the specificity of homology subtraction and the sensitivity of heterologous sequence detection.
Two kinds of hybrid duplexes can be formed: (i) the tester-tester homohybrid duplexes, which consist of desired heterologous (different) sequences only present in tester but almost absent in subtracter, and (ii) the tester-subtracter heterohybrid duplexes, which consist of homologous (common) sequences present in both tester and subtracter. Because the carboxyl groups of a modified subtracter covalently bond with the amino groups of a tester DNA, the tester-subtracter heterohybrid duplexes cannot be amplified by PCR or vector cloning, in that each round of the amplification requires the separation of DNA duplexes. However, the testertester homohybrid duplexes are formed by hydrogen bonds that can be separated during PCR or vector cloning to complete their own amplification. Therefore, the amounts of the desired different sequences are greatly multified after PCR or vector cloning; whereas, the amounts of common sequences will become negligible.
The ratio of subtracter to tester DNA is in a preferred range of about 5:1 to 20:1. If the ratio of subtracter to tester is higher than 5:1, successful enrichment of sequences, which are only up-or down-regulated by severalfold, will not be obtained. If the ratio of subtracter to tester is too low, homologues will not be completely competed out and would cause false-positive results that would need to be removed by more rounds of subtraction. The optimal ratio of subtracter to tester DNA for isolating a particular sequence will vary depending on the level of its transcriptional difference between tester and subtracter.
The subtracted tester DNA can be subjected to another round of subtractive hybridization or amplification. The final subtracted or selectively amplified sequences are used for DNA library selection assay and cloning analysis, and represent the desired different DNA sequences that are stimulated or up-regulated in the treated, mutated, infected, differentiated or abnormal cells. By the same token, the tester and subtracter steps can be performed in a reverse order to isolate the suppressed or downregulated sequences. The final isolated sequences can then be used to probe the full-length mRNA or cDNA from the tester library (if cDNA tester is used as a sample) or to locate the deleted/inserted loci in a special chromosome by in situ hybridization (if genomic DNA is used as a sample). The information so obtained could provide further understanding of a variety of diseases, physiological phenomena and genetic functions.
The CHS assay could be very useful in the identification of differential gene expression involved in development, cell differentiation, aging and a variety of pathological disorders, such as cancer formation, genetic defects, autoimmune diseases and other disorders related to genetic malfunction. The identification of these differentially expressed genes will help the determination of their open reading frames and corresponding peptides, which might contribute to a specific drug design or therapy for the regulation of theses genes. Alternatively, the present invention can also be used to screen some types of chromosomal abnormalities, such as deletions and insertions. Because restricted genomic fragments of less than one kilobase are prepared as starting samples for subtractive hybridization (7), the target deletion or insertion must be larger than this size for efficient amplification. The identification of these chromosomal deletions or insertions might contribute to the diagnosis or prognosis of certain virus infections, inherent problems or developmental defects. Taken together, the CHS assay is capable of providing a variety of information useful for understanding changes in gene expression and the differences between genomes.
